Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 11.65% | 8.30% | 7.02% | 4.32% | 2.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.65% | 8.30% | 7.02% | 4.32% | 2.87% |
| Cost of Revenue | 7.06% | 8.18% | 7.28% | 2.67% | 0.75% |
| Gross Profit | 18.89% | 8.48% | 6.62% | 7.02% | 6.41% |
| SG&A Expenses | 1.84% | -- | -- | -- | -1.31% |
| Depreciation & Amortization | 5.20% | 2.67% | 3.39% | 3.28% | 3.02% |
| Other Operating Expenses | 36.87% | 18.15% | 13.00% | 5.16% | 21.06% |
| Total Operating Expenses | 10.84% | 10.08% | 8.28% | 3.24% | 3.20% |
| Operating Income | 16.08% | -2.38% | 0.17% | 10.59% | 1.13% |
| Income Before Tax | -28.98% | -4.34% | 2.78% | 5.95% | 27.69% |
| Income Tax Expenses | -26.22% | -1.39% | 4.20% | 8.60% | 12.91% |
| Earnings from Continuing Operations | -29.67% | -5.13% | 2.39% | 5.32% | 31.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 55.04% | 6.67% | 2.23% | 6.25% | -195.81% |
| Net Income | -22.78% | -4.85% | 3.29% | 7.07% | 14.72% |
| EBIT | 16.08% | -2.38% | 0.17% | 10.59% | 1.13% |
| EBITDA | 13.50% | -1.07% | 0.96% | 8.76% | 1.57% |
| EPS Basic | -18.66% | 0.34% | 10.07% | 16.94% | 26.67% |
| Normalized Basic EPS | 89.81% | 1.10% | 2.76% | 20.33% | -31.08% |
| EPS Diluted | -18.59% | 0.00% | 10.00% | 17.15% | 26.57% |
| Normalized Diluted EPS | 89.81% | 0.89% | 2.62% | 20.53% | -31.08% |
| Average Basic Shares Outstanding | -5.07% | -5.17% | -6.16% | -8.44% | -9.43% |
| Average Diluted Shares Outstanding | -5.07% | -4.98% | -6.03% | -8.59% | -9.43% |
| Dividend Per Share | 7.14% | 7.14% | 7.14% | 7.14% | 16.67% |
| Payout Ratio | 0.33% | 0.06% | -0.01% | -0.08% | -0.08% |